Medical Care

Global IgG2a Antibody Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for IgG2a Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IgG2a Antibody.
The IgG2a Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global IgG2a Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IgG2a Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Bio X Cell
Aviva Systems Biology
R&D Systems
Biorbyt
RayBiotech
MyBioSource
BioLegend
Thermo Fisher Scientific
Novus Biologicals
SouthernBiotech
Mabtech
Cell Sciences
American Research Products
Abeomics
LI-COR Biosciences
RevMAb Biosciences
OriGene Technologies
Proteintech Group
QED Bioscience
Miltenyi Biotec
Absolute Antibody
Synaptic Systems
Bethyl Laboratories
Tonbo Biosciences
LSBio
Merck
NSJ Bioreagents
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IgG2a Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IgG2a Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global IgG2a Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IgG2a Antibody Market Perspective (2020-2031)
2.2 Global IgG2a Antibody Growth Trends by Region
2.2.1 Global IgG2a Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 IgG2a Antibody Historic Market Size by Region (2020-2025)
2.2.3 IgG2a Antibody Forecasted Market Size by Region (2026-2031)
2.3 IgG2a Antibody Market Dynamics
2.3.1 IgG2a Antibody Industry Trends
2.3.2 IgG2a Antibody Market Drivers
2.3.3 IgG2a Antibody Market Challenges
2.3.4 IgG2a Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IgG2a Antibody Players by Revenue
3.1.1 Global Top IgG2a Antibody Players by Revenue (2020-2025)
3.1.2 Global IgG2a Antibody Revenue Market Share by Players (2020-2025)
3.2 Global IgG2a Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by IgG2a Antibody Revenue
3.4 Global IgG2a Antibody Market Concentration Ratio
3.4.1 Global IgG2a Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IgG2a Antibody Revenue in 2024
3.5 Global Key Players of IgG2a Antibody Head office and Area Served
3.6 Global Key Players of IgG2a Antibody, Product and Application
3.7 Global Key Players of IgG2a Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 IgG2a Antibody Breakdown Data by Type
4.1 Global IgG2a Antibody Historic Market Size by Type (2020-2025)
4.2 Global IgG2a Antibody Forecasted Market Size by Type (2026-2031)
5 IgG2a Antibody Breakdown Data by Application
5.1 Global IgG2a Antibody Historic Market Size by Application (2020-2025)
5.2 Global IgG2a Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America IgG2a Antibody Market Size (2020-2031)
6.2 North America IgG2a Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America IgG2a Antibody Market Size by Country (2020-2025)
6.4 North America IgG2a Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IgG2a Antibody Market Size (2020-2031)
7.2 Europe IgG2a Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe IgG2a Antibody Market Size by Country (2020-2025)
7.4 Europe IgG2a Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IgG2a Antibody Market Size (2020-2031)
8.2 Asia-Pacific IgG2a Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific IgG2a Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific IgG2a Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IgG2a Antibody Market Size (2020-2031)
9.2 Latin America IgG2a Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America IgG2a Antibody Market Size by Country (2020-2025)
9.4 Latin America IgG2a Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IgG2a Antibody Market Size (2020-2031)
10.2 Middle East & Africa IgG2a Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa IgG2a Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa IgG2a Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Details
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad IgG2a Antibody Introduction
11.1.4 Bio-Rad Revenue in IgG2a Antibody Business (2020-2025)
11.1.5 Bio-Rad Recent Development
11.2 Bio X Cell
11.2.1 Bio X Cell Company Details
11.2.2 Bio X Cell Business Overview
11.2.3 Bio X Cell IgG2a Antibody Introduction
11.2.4 Bio X Cell Revenue in IgG2a Antibody Business (2020-2025)
11.2.5 Bio X Cell Recent Development
11.3 Aviva Systems Biology
11.3.1 Aviva Systems Biology Company Details
11.3.2 Aviva Systems Biology Business Overview
11.3.3 Aviva Systems Biology IgG2a Antibody Introduction
11.3.4 Aviva Systems Biology Revenue in IgG2a Antibody Business (2020-2025)
11.3.5 Aviva Systems Biology Recent Development
11.4 R&D Systems
11.4.1 R&D Systems Company Details
11.4.2 R&D Systems Business Overview
11.4.3 R&D Systems IgG2a Antibody Introduction
11.4.4 R&D Systems Revenue in IgG2a Antibody Business (2020-2025)
11.4.5 R&D Systems Recent Development
11.5 Biorbyt
11.5.1 Biorbyt Company Details
11.5.2 Biorbyt Business Overview
11.5.3 Biorbyt IgG2a Antibody Introduction
11.5.4 Biorbyt Revenue in IgG2a Antibody Business (2020-2025)
11.5.5 Biorbyt Recent Development
11.6 RayBiotech
11.6.1 RayBiotech Company Details
11.6.2 RayBiotech Business Overview
11.6.3 RayBiotech IgG2a Antibody Introduction
11.6.4 RayBiotech Revenue in IgG2a Antibody Business (2020-2025)
11.6.5 RayBiotech Recent Development
11.7 MyBioSource
11.7.1 MyBioSource Company Details
11.7.2 MyBioSource Business Overview
11.7.3 MyBioSource IgG2a Antibody Introduction
11.7.4 MyBioSource Revenue in IgG2a Antibody Business (2020-2025)
11.7.5 MyBioSource Recent Development
11.8 BioLegend
11.8.1 BioLegend Company Details
11.8.2 BioLegend Business Overview
11.8.3 BioLegend IgG2a Antibody Introduction
11.8.4 BioLegend Revenue in IgG2a Antibody Business (2020-2025)
11.8.5 BioLegend Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific IgG2a Antibody Introduction
11.9.4 Thermo Fisher Scientific Revenue in IgG2a Antibody Business (2020-2025)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Novus Biologicals
11.10.1 Novus Biologicals Company Details
11.10.2 Novus Biologicals Business Overview
11.10.3 Novus Biologicals IgG2a Antibody Introduction
11.10.4 Novus Biologicals Revenue in IgG2a Antibody Business (2020-2025)
11.10.5 Novus Biologicals Recent Development
11.11 SouthernBiotech
11.11.1 SouthernBiotech Company Details
11.11.2 SouthernBiotech Business Overview
11.11.3 SouthernBiotech IgG2a Antibody Introduction
11.11.4 SouthernBiotech Revenue in IgG2a Antibody Business (2020-2025)
11.11.5 SouthernBiotech Recent Development
11.12 Mabtech
11.12.1 Mabtech Company Details
11.12.2 Mabtech Business Overview
11.12.3 Mabtech IgG2a Antibody Introduction
11.12.4 Mabtech Revenue in IgG2a Antibody Business (2020-2025)
11.12.5 Mabtech Recent Development
11.13 Cell Sciences
11.13.1 Cell Sciences Company Details
11.13.2 Cell Sciences Business Overview
11.13.3 Cell Sciences IgG2a Antibody Introduction
11.13.4 Cell Sciences Revenue in IgG2a Antibody Business (2020-2025)
11.13.5 Cell Sciences Recent Development
11.14 American Research Products
11.14.1 American Research Products Company Details
11.14.2 American Research Products Business Overview
11.14.3 American Research Products IgG2a Antibody Introduction
11.14.4 American Research Products Revenue in IgG2a Antibody Business (2020-2025)
11.14.5 American Research Products Recent Development
11.15 Abeomics
11.15.1 Abeomics Company Details
11.15.2 Abeomics Business Overview
11.15.3 Abeomics IgG2a Antibody Introduction
11.15.4 Abeomics Revenue in IgG2a Antibody Business (2020-2025)
11.15.5 Abeomics Recent Development
11.16 LI-COR Biosciences
11.16.1 LI-COR Biosciences Company Details
11.16.2 LI-COR Biosciences Business Overview
11.16.3 LI-COR Biosciences IgG2a Antibody Introduction
11.16.4 LI-COR Biosciences Revenue in IgG2a Antibody Business (2020-2025)
11.16.5 LI-COR Biosciences Recent Development
11.17 RevMAb Biosciences
11.17.1 RevMAb Biosciences Company Details
11.17.2 RevMAb Biosciences Business Overview
11.17.3 RevMAb Biosciences IgG2a Antibody Introduction
11.17.4 RevMAb Biosciences Revenue in IgG2a Antibody Business (2020-2025)
11.17.5 RevMAb Biosciences Recent Development
11.18 OriGene Technologies
11.18.1 OriGene Technologies Company Details
11.18.2 OriGene Technologies Business Overview
11.18.3 OriGene Technologies IgG2a Antibody Introduction
11.18.4 OriGene Technologies Revenue in IgG2a Antibody Business (2020-2025)
11.18.5 OriGene Technologies Recent Development
11.19 Proteintech Group
11.19.1 Proteintech Group Company Details
11.19.2 Proteintech Group Business Overview
11.19.3 Proteintech Group IgG2a Antibody Introduction
11.19.4 Proteintech Group Revenue in IgG2a Antibody Business (2020-2025)
11.19.5 Proteintech Group Recent Development
11.20 QED Bioscience
11.20.1 QED Bioscience Company Details
11.20.2 QED Bioscience Business Overview
11.20.3 QED Bioscience IgG2a Antibody Introduction
11.20.4 QED Bioscience Revenue in IgG2a Antibody Business (2020-2025)
11.20.5 QED Bioscience Recent Development
11.21 Miltenyi Biotec
11.21.1 Miltenyi Biotec Company Details
11.21.2 Miltenyi Biotec Business Overview
11.21.3 Miltenyi Biotec IgG2a Antibody Introduction
11.21.4 Miltenyi Biotec Revenue in IgG2a Antibody Business (2020-2025)
11.21.5 Miltenyi Biotec Recent Development
11.22 Absolute Antibody
11.22.1 Absolute Antibody Company Details
11.22.2 Absolute Antibody Business Overview
11.22.3 Absolute Antibody IgG2a Antibody Introduction
11.22.4 Absolute Antibody Revenue in IgG2a Antibody Business (2020-2025)
11.22.5 Absolute Antibody Recent Development
11.23 Synaptic Systems
11.23.1 Synaptic Systems Company Details
11.23.2 Synaptic Systems Business Overview
11.23.3 Synaptic Systems IgG2a Antibody Introduction
11.23.4 Synaptic Systems Revenue in IgG2a Antibody Business (2020-2025)
11.23.5 Synaptic Systems Recent Development
11.24 Bethyl Laboratories
11.24.1 Bethyl Laboratories Company Details
11.24.2 Bethyl Laboratories Business Overview
11.24.3 Bethyl Laboratories IgG2a Antibody Introduction
11.24.4 Bethyl Laboratories Revenue in IgG2a Antibody Business (2020-2025)
11.24.5 Bethyl Laboratories Recent Development
11.25 Tonbo Biosciences
11.25.1 Tonbo Biosciences Company Details
11.25.2 Tonbo Biosciences Business Overview
11.25.3 Tonbo Biosciences IgG2a Antibody Introduction
11.25.4 Tonbo Biosciences Revenue in IgG2a Antibody Business (2020-2025)
11.25.5 Tonbo Biosciences Recent Development
11.26 LSBio
11.26.1 LSBio Company Details
11.26.2 LSBio Business Overview
11.26.3 LSBio IgG2a Antibody Introduction
11.26.4 LSBio Revenue in IgG2a Antibody Business (2020-2025)
11.26.5 LSBio Recent Development
11.27 Merck
11.27.1 Merck Company Details
11.27.2 Merck Business Overview
11.27.3 Merck IgG2a Antibody Introduction
11.27.4 Merck Revenue in IgG2a Antibody Business (2020-2025)
11.27.5 Merck Recent Development
11.28 NSJ Bioreagents
11.28.1 NSJ Bioreagents Company Details
11.28.2 NSJ Bioreagents Business Overview
11.28.3 NSJ Bioreagents IgG2a Antibody Introduction
11.28.4 NSJ Bioreagents Revenue in IgG2a Antibody Business (2020-2025)
11.28.5 NSJ Bioreagents Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global IgG2a Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of Polyclonal Antibody
Table 4. Global IgG2a Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global IgG2a Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global IgG2a Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global IgG2a Antibody Market Share by Region (2020-2025)
Table 8. Global IgG2a Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global IgG2a Antibody Market Share by Region (2026-2031)
Table 10. IgG2a Antibody Market Trends
Table 11. IgG2a Antibody Market Drivers
Table 12. IgG2a Antibody Market Challenges
Table 13. IgG2a Antibody Market Restraints
Table 14. Global IgG2a Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global IgG2a Antibody Market Share by Players (2020-2025)
Table 16. Global Top IgG2a Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgG2a Antibody as of 2024)
Table 17. Ranking of Global Top IgG2a Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by IgG2a Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of IgG2a Antibody, Headquarters and Area Served
Table 20. Global Key Players of IgG2a Antibody, Product and Application
Table 21. Global Key Players of IgG2a Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global IgG2a Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global IgG2a Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global IgG2a Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global IgG2a Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global IgG2a Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global IgG2a Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global IgG2a Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global IgG2a Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America IgG2a Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America IgG2a Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America IgG2a Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe IgG2a Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe IgG2a Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe IgG2a Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific IgG2a Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific IgG2a Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific IgG2a Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America IgG2a Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America IgG2a Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America IgG2a Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa IgG2a Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa IgG2a Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa IgG2a Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bio-Rad Company Details
Table 47. Bio-Rad Business Overview
Table 48. Bio-Rad IgG2a Antibody Product
Table 49. Bio-Rad Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 50. Bio-Rad Recent Development
Table 51. Bio X Cell Company Details
Table 52. Bio X Cell Business Overview
Table 53. Bio X Cell IgG2a Antibody Product
Table 54. Bio X Cell Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 55. Bio X Cell Recent Development
Table 56. Aviva Systems Biology Company Details
Table 57. Aviva Systems Biology Business Overview
Table 58. Aviva Systems Biology IgG2a Antibody Product
Table 59. Aviva Systems Biology Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 60. Aviva Systems Biology Recent Development
Table 61. R&D Systems Company Details
Table 62. R&D Systems Business Overview
Table 63. R&D Systems IgG2a Antibody Product
Table 64. R&D Systems Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 65. R&D Systems Recent Development
Table 66. Biorbyt Company Details
Table 67. Biorbyt Business Overview
Table 68. Biorbyt IgG2a Antibody Product
Table 69. Biorbyt Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 70. Biorbyt Recent Development
Table 71. RayBiotech Company Details
Table 72. RayBiotech Business Overview
Table 73. RayBiotech IgG2a Antibody Product
Table 74. RayBiotech Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 75. RayBiotech Recent Development
Table 76. MyBioSource Company Details
Table 77. MyBioSource Business Overview
Table 78. MyBioSource IgG2a Antibody Product
Table 79. MyBioSource Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 80. MyBioSource Recent Development
Table 81. BioLegend Company Details
Table 82. BioLegend Business Overview
Table 83. BioLegend IgG2a Antibody Product
Table 84. BioLegend Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 85. BioLegend Recent Development
Table 86. Thermo Fisher Scientific Company Details
Table 87. Thermo Fisher Scientific Business Overview
Table 88. Thermo Fisher Scientific IgG2a Antibody Product
Table 89. Thermo Fisher Scientific Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 90. Thermo Fisher Scientific Recent Development
Table 91. Novus Biologicals Company Details
Table 92. Novus Biologicals Business Overview
Table 93. Novus Biologicals IgG2a Antibody Product
Table 94. Novus Biologicals Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 95. Novus Biologicals Recent Development
Table 96. SouthernBiotech Company Details
Table 97. SouthernBiotech Business Overview
Table 98. SouthernBiotech IgG2a Antibody Product
Table 99. SouthernBiotech Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 100. SouthernBiotech Recent Development
Table 101. Mabtech Company Details
Table 102. Mabtech Business Overview
Table 103. Mabtech IgG2a Antibody Product
Table 104. Mabtech Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 105. Mabtech Recent Development
Table 106. Cell Sciences Company Details
Table 107. Cell Sciences Business Overview
Table 108. Cell Sciences IgG2a Antibody Product
Table 109. Cell Sciences Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 110. Cell Sciences Recent Development
Table 111. American Research Products Company Details
Table 112. American Research Products Business Overview
Table 113. American Research Products IgG2a Antibody Product
Table 114. American Research Products Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 115. American Research Products Recent Development
Table 116. Abeomics Company Details
Table 117. Abeomics Business Overview
Table 118. Abeomics IgG2a Antibody Product
Table 119. Abeomics Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 120. Abeomics Recent Development
Table 121. LI-COR Biosciences Company Details
Table 122. LI-COR Biosciences Business Overview
Table 123. LI-COR Biosciences IgG2a Antibody Product
Table 124. LI-COR Biosciences Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 125. LI-COR Biosciences Recent Development
Table 126. RevMAb Biosciences Company Details
Table 127. RevMAb Biosciences Business Overview
Table 128. RevMAb Biosciences IgG2a Antibody Product
Table 129. RevMAb Biosciences Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 130. RevMAb Biosciences Recent Development
Table 131. OriGene Technologies Company Details
Table 132. OriGene Technologies Business Overview
Table 133. OriGene Technologies IgG2a Antibody Product
Table 134. OriGene Technologies Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 135. OriGene Technologies Recent Development
Table 136. Proteintech Group Company Details
Table 137. Proteintech Group Business Overview
Table 138. Proteintech Group IgG2a Antibody Product
Table 139. Proteintech Group Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 140. Proteintech Group Recent Development
Table 141. QED Bioscience Company Details
Table 142. QED Bioscience Business Overview
Table 143. QED Bioscience IgG2a Antibody Product
Table 144. QED Bioscience Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 145. QED Bioscience Recent Development
Table 146. Miltenyi Biotec Company Details
Table 147. Miltenyi Biotec Business Overview
Table 148. Miltenyi Biotec IgG2a Antibody Product
Table 149. Miltenyi Biotec Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 150. Miltenyi Biotec Recent Development
Table 151. Absolute Antibody Company Details
Table 152. Absolute Antibody Business Overview
Table 153. Absolute Antibody IgG2a Antibody Product
Table 154. Absolute Antibody Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 155. Absolute Antibody Recent Development
Table 156. Synaptic Systems Company Details
Table 157. Synaptic Systems Business Overview
Table 158. Synaptic Systems IgG2a Antibody Product
Table 159. Synaptic Systems Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 160. Synaptic Systems Recent Development
Table 161. Bethyl Laboratories Company Details
Table 162. Bethyl Laboratories Business Overview
Table 163. Bethyl Laboratories IgG2a Antibody Product
Table 164. Bethyl Laboratories Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 165. Bethyl Laboratories Recent Development
Table 166. Tonbo Biosciences Company Details
Table 167. Tonbo Biosciences Business Overview
Table 168. Tonbo Biosciences IgG2a Antibody Product
Table 169. Tonbo Biosciences Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 170. Tonbo Biosciences Recent Development
Table 171. LSBio Company Details
Table 172. LSBio Business Overview
Table 173. LSBio IgG2a Antibody Product
Table 174. LSBio Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 175. LSBio Recent Development
Table 176. Merck Company Details
Table 177. Merck Business Overview
Table 178. Merck IgG2a Antibody Product
Table 179. Merck Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 180. Merck Recent Development
Table 181. NSJ Bioreagents Company Details
Table 182. NSJ Bioreagents Business Overview
Table 183. NSJ Bioreagents IgG2a Antibody Product
Table 184. NSJ Bioreagents Revenue in IgG2a Antibody Business (2020-2025) & (US$ Million)
Table 185. NSJ Bioreagents Recent Development
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
Table 189. Authors List of This Report


List of Figures
Figure 1. IgG2a Antibody Picture
Figure 2. Global IgG2a Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global IgG2a Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibody Features
Figure 5. Polyclonal Antibody Features
Figure 6. Global IgG2a Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global IgG2a Antibody Market Share by Application: 2024 VS 2031
Figure 8. Biotechnology Case Studies
Figure 9. Medical Case Studies
Figure 10. University Case Studies
Figure 11. Others Case Studies
Figure 12. IgG2a Antibody Report Years Considered
Figure 13. Global IgG2a Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global IgG2a Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global IgG2a Antibody Market Share by Region: 2024 VS 2031
Figure 16. Global IgG2a Antibody Market Share by Players in 2024
Figure 17. Global Top IgG2a Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgG2a Antibody as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by IgG2a Antibody Revenue in 2024
Figure 19. North America IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America IgG2a Antibody Market Share by Country (2020-2031)
Figure 21. United States IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe IgG2a Antibody Market Share by Country (2020-2031)
Figure 25. Germany IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific IgG2a Antibody Market Share by Region (2020-2031)
Figure 33. China IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America IgG2a Antibody Market Share by Country (2020-2031)
Figure 41. Mexico IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa IgG2a Antibody Market Share by Country (2020-2031)
Figure 45. Turkey IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE IgG2a Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Bio-Rad Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 49. Bio X Cell Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 50. Aviva Systems Biology Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 51. R&D Systems Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 52. Biorbyt Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 53. RayBiotech Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 54. MyBioSource Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 55. BioLegend Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 57. Novus Biologicals Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 58. SouthernBiotech Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 59. Mabtech Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 60. Cell Sciences Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 61. American Research Products Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 62. Abeomics Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 63. LI-COR Biosciences Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 64. RevMAb Biosciences Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 65. OriGene Technologies Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 66. Proteintech Group Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 67. QED Bioscience Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 68. Miltenyi Biotec Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 69. Absolute Antibody Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 70. Synaptic Systems Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 71. Bethyl Laboratories Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 72. Tonbo Biosciences Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 73. LSBio Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 74. Merck Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 75. NSJ Bioreagents Revenue Growth Rate in IgG2a Antibody Business (2020-2025)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies